There is no doubt that once PRR lists on the NASDAQ we will see a massive spike in the share price.
An example of another biotech company is UNS. In the month leading to listing it went from $1.055 to $1.40. Upon listing it shot to $1.78. It has now retraced to $0.82 due to mismanagement etc.
PRR is a diffferent kettle of fish though with more potential. If UNS was able to go up 70%, PRR will be able to double it's current price upon listing.
Please DYOR as my research is based on historical data and events.
There is no doubt that once PRR lists on the NASDAQ we will see...
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
-0.040(11.9%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 33.0¢ | 28.0¢ | $7.278M | 23.75M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 53192 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 41048 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |